These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

495 related articles for article (PubMed ID: 30200265)

  • 21. Mesothelial-to-mesenchymal transition as a possible therapeutic target in peritoneal metastasis of ovarian cancer.
    Rynne-Vidal A; Au-Yeung CL; Jiménez-Heffernan JA; Pérez-Lozano ML; Cremades-Jimeno L; Bárcena C; Cristóbal-García I; Fernández-Chacón C; Yeung TL; Mok SC; Sandoval P; López-Cabrera M
    J Pathol; 2017 Jun; 242(2):140-151. PubMed ID: 28247413
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modeling the Early Steps of Ovarian Cancer Dissemination in an Organotypic Culture of the Human Peritoneal Cavity.
    Peters PN; Schryver EM; Lengyel E; Kenny H
    J Vis Exp; 2015 Dec; (106):e53541. PubMed ID: 26780294
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epigenomics in stress tolerance of plants under the climate change.
    Kumar M; Rani K
    Mol Biol Rep; 2023 Jul; 50(7):6201-6216. PubMed ID: 37294468
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Unique Molecular and Cellular Microenvironment of Ovarian Cancer.
    Worzfeld T; Pogge von Strandmann E; Huber M; Adhikary T; Wagner U; Reinartz S; Müller R
    Front Oncol; 2017; 7():24. PubMed ID: 28275576
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel mechanism of neovascularization in peritoneal dissemination via cancer-associated mesothelial cells affected by TGF-β derived from ovarian cancer.
    Fujikake K; Kajiyama H; Yoshihara M; Nishino K; Yoshikawa N; Utsumi F; Suzuki S; Niimi K; Sakata J; Mitsui H; Shibata K; Senga T; Kikkawa F
    Oncol Rep; 2018 Jan; 39(1):193-200. PubMed ID: 29192324
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fibroblasts in omentum activated by tumor cells promote ovarian cancer growth, adhesion and invasiveness.
    Cai J; Tang H; Xu L; Wang X; Yang C; Ruan S; Guo J; Hu S; Wang Z
    Carcinogenesis; 2012 Jan; 33(1):20-9. PubMed ID: 22021907
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An evolving story of the metastatic voyage of ovarian cancer cells: cellular and molecular orchestration of the adipose-rich metastatic microenvironment.
    Motohara T; Masuda K; Morotti M; Zheng Y; El-Sahhar S; Chong KY; Wietek N; Alsaadi A; Carrami EM; Hu Z; Artibani M; Gonzalez LS; Katabuchi H; Saya H; Ahmed AA
    Oncogene; 2019 Apr; 38(16):2885-2898. PubMed ID: 30568223
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adipocytes: active facilitators in epithelial ovarian cancer progression?
    Dai L; Song K; Di W
    J Ovarian Res; 2020 Sep; 13(1):115. PubMed ID: 32967712
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modeling the Early Steps of Ovarian Cancer Dissemination in an Organotypic Culture of the Human Peritoneal Cavity.
    Hart PC; Bajwa P; Kenny HA
    Adv Exp Med Biol; 2021; 1330():75-94. PubMed ID: 34339031
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of AKT activity is associated with reversible dormancy in ascites-derived epithelial ovarian cancer spheroids.
    Correa RJ; Peart T; Valdes YR; DiMattia GE; Shepherd TG
    Carcinogenesis; 2012 Jan; 33(1):49-58. PubMed ID: 22045027
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cadherin composition and multicellular aggregate invasion in organotypic models of epithelial ovarian cancer intraperitoneal metastasis.
    Klymenko Y; Kim O; Loughran E; Yang J; Lombard R; Alber M; Stack MS
    Oncogene; 2017 Oct; 36(42):5840-5851. PubMed ID: 28628116
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor-associated fibrosis: a unique mechanism promoting ovarian cancer metastasis and peritoneal dissemination.
    Fujimoto H; Yoshihara M; Rodgers R; Iyoshi S; Mogi K; Miyamoto E; Hayakawa S; Hayashi M; Nomura S; Kitami K; Uno K; Sugiyama M; Koya Y; Yamakita Y; Nawa A; Enomoto A; Ricciardelli C; Kajiyama H
    Cancer Metastasis Rev; 2024 Mar; ():. PubMed ID: 38546906
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ovarian cancer-derived ascitic fluids induce a senescence-dependent pro-cancerogenic phenotype in normal peritoneal mesothelial cells.
    Mikuła-Pietrasik J; Uruski P; Matuszkiewicz K; Szubert S; Moszyński R; Szpurek D; Sajdak S; Tykarski A; Książek K
    Cell Oncol (Dordr); 2016 Oct; 39(5):473-481. PubMed ID: 27444787
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epigenetic modifications in colorectal cancer: molecular insights and therapeutic challenges.
    Vaiopoulos AG; Athanasoula KCh; Papavassiliou AG
    Biochim Biophys Acta; 2014 Jul; 1842(7):971-80. PubMed ID: 24561654
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Re-purposing of curcumin as an anti-metastatic agent for the treatment of epithelial ovarian cancer: in vitro model using cancer stem cell enriched ovarian cancer spheroids.
    He M; Wang D; Zou D; Wang C; Lopes-Bastos B; Jiang WG; Chester J; Zhou Q; Cai J
    Oncotarget; 2016 Dec; 7(52):86374-86387. PubMed ID: 27863439
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Emerging Roles and Therapeutic Implications of Epigenetic Modifications in Ovarian Cancer.
    Wang Y; Huang Z; Li B; Liu L; Huang C
    Front Endocrinol (Lausanne); 2022; 13():863541. PubMed ID: 35620395
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epigenetic Modifications and Head and Neck Cancer: Implications for Tumor Progression and Resistance to Therapy.
    Castilho RM; Squarize CH; Almeida LO
    Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28704968
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The crosstalk between m
    Zhao Y; Chen Y; Jin M; Wang J
    Theranostics; 2021; 11(9):4549-4566. PubMed ID: 33754077
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epigenetic regulation and therapeutic targets in the tumor microenvironment.
    Xie Z; Zhou Z; Yang S; Zhang S; Shao B
    Mol Biomed; 2023 Jun; 4(1):17. PubMed ID: 37273004
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distinct promotor methylation at tumor suppressive genes in ovarian cancer stromal progenitor cells and ovarian cancer and its clinical implication.
    Ho CM; Yen TL; Chien TY; Huang SH
    Am J Cancer Res; 2022; 12(11):5325-5341. PubMed ID: 36504889
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.